Amanda Bronstad

Amanda Bronstad is the ALM staff reporter covering class actions and mass torts nationwide. She writes the email dispatch Law.com Class Actions: Critical Mass. She is based in Los Angeles.

Connect with this author

March 20, 2024 | Law.com

Critical Mass With Law.com's Amanda Bronstad: Ozempic Judge Tells Lawyers, 'Life is Way Too Short to be Cranky,' DuPont PFAS Settlement Class Counsel Wants Ex-Objector Lawyers Sanctioned

By Amanda Bronstad

7 minute read

March 19, 2024 | Law.com

DuPont Water Settlement Class Counsel Moves to Sanction Lawyers: 'False, Slanderous, Meritless and Vexatious Conduct'

A March 15 sanctions motion accused the Metropolitan Water District of Southern California's lawyers of a "bad-faith course of conduct" that includes libeling class counsel, disseminating the wrong information to class members and filing frivolous objections.

By Amanda Bronstad

6 minute read

March 18, 2024 | Law.com

Opioid Judge Rejects DQ Motion, But Cautions Motley Rice: 'The Court Frowns'

U.S. District Judge Dan Polster on Monday declined to disqualify Motley Rice from dozens of opioid cases, but said he was "very uncomfortable" with its government client arrangements.

By Amanda Bronstad

5 minute read

March 15, 2024 | Law.com

Another Defendant Says Motley Rice Should Be Disqualified From Opioid Litigation

Express Scripts Inc., a pharmacy benefit manager facing upcoming bellwether trials over the opioid crisis, filed a March 13 brief referencing a subpoena that Motley Rice member Linda Singer sent to the company on behalf of the city of Chicago.

By Amanda Bronstad

4 minute read

March 15, 2024 | Law.com

Social Media Ads Inject New Angle in Ozempic Cases: 'It's Going to Be a Huge Focus'

The proliferation of advertising on social media for Ozempic and related drugs will be a key part of the lawsuits against Novo Nordisk and Eli Lilly.

By Amanda Bronstad

6 minute read

March 14, 2024 | Law.com

Mead Johnson Hit With $60M Verdict in First NEC Trial Over Preterm Infant Formula

An Illinois jury awarded $60 million on Wednesday in the first verdict involving cow's milk-based infant formula that allegedly has sickened or killed premature babies who contracted a gastrointestinal inflammation called necrotizing enterocolitis, or NEC.

By Amanda Bronstad

5 minute read

March 13, 2024 | Law.com

Critical Mass With Law.com's Amanda Bronstad: 80% of Claims in Altria's Juul Settlement Are Fraudulent or Invalid, Motley Rice Turns to ABA Rule in Opioid DQ Defense

By Amanda Bronstad

6 minute read

March 11, 2024 | Law.com

Motley Rice Cites ABA Ethics Opinion in Opioid Disqualification Duel

The disqualification motion comes as U.S. District Judge Dan Polster, who is overseeing the opioid multidistrict litigation, has lined up four bellwether trials against OptumRx and another pharmacy benefit manager, Express Scripts.

By Amanda Bronstad

5 minute read

March 11, 2024 | Law.com

Q&A With Scott + Scott's Fatima Brizuela: How Algorithmic Pricing Changed Antitrust Law

Brizuela, who joined Scott + Scott's San Diego office last year, is involved in some of the most cutting-edge antitrust cases, suing crude oil producers over high gas prices and real estate management software provider RealPage over its algorithmic pricing.

By Amanda Bronstad

6 minute read

March 06, 2024 | The Recorder

'Barrage of Suspect Claims' Hampers Altria Class Settlement With Juul Users

At a Wednesday hearing, lawyers predicted that as many as 80% of the claims made in Altria's $45.5 million class settlement over Juul could be invalid or fraudulent.

By Amanda Bronstad

5 minute read

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.